Integrated Filing — IndAS



General information about company
Scrip Code 531209
NSE Symbol NUCLEUS
MSEI Symbol NOTLISTED
ISIN INE096B01018
Name of company NUCLEUS SOFTWARE EXPORTS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 16-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 28-Apr-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 16-May-2025   09:30:00
End date and time of board meeting 16-May-2025   13:40:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-01-28
Indicate Company website link for updated RPT policy of the Company https://investor.nucleussoftware.com/CorporateGovernance.aspx
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NOT APPLICABLE



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 2129100000 7686600000
Other income 166100000 700400000
Total income 2295200000 8387000000
2 Expenses
(a) Cost of materials consumed 0 0
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0 0
(d) Employee benefit expense 1067700000 4723500000
(e) Finance costs 1200000 5500000
(f) Depreciation, depletion and amortisation expense 31600000 138400000
(f) Other Expenses
1 Operating and other expenses 345200000 1361800000
Total other expenses 345200000 1361800000
Total expenses 1445700000 6229200000
3 Total profit before exceptional items and tax 849500000 2157800000
4 Exceptional items 0 0
5 Total profit before tax 849500000 2157800000
6 Tax expense
7 Current tax 195900000 455200000
8 Deferred tax 21600000 85000000
9 Total tax expenses 217500000 540200000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 632000000 1617600000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 632000000 1617600000
17 Other comprehensive income net of taxes 9800000 -48300000
18 Total Comprehensive Income for the period 641800000 1569300000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 263300000 263300000
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 0
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 24.01 60.93
Diluted earnings (loss) per share from continuing operations 24.01 60.93
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 24.01 60.93
Diluted earnings (loss) per share from continuing and discontinued operations 24.01 60.93
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 400900000
Capital work-in-progress 2200000
Investment property 0
Goodwill 0
Other intangible assets 78300000
Intangible assets under development 300000
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 4234700000
Trade receivables, non-current 0
Loans, non-current 800000
Other non-current financial assets 1250300000
Total non-current financial assets 5485800000
Deferred tax assets (net) 0
Other non-current assets 180500000
Total non-current assets 6148000000
2 Current assets
Inventories 0
Current financial asset
Current investments 2321700000
Trade receivables, current 1289900000
Cash and cash equivalents 188500000
Bank balance other than cash and cash equivalents 722100000
Loans, current 7400000
Other current financial assets 14900000
Total current financial assets 4544500000
Current tax assets (net) 0
Other current assets 412000000
Total current assets 4956500000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 11104500000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 263300000
Other equity 7570000000
Total equity attributable to owners of parent 7833300000
Non controlling interest
Total equity 7833300000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 8800000
Total non-current financial liabilities 8800000
Provisions, non-current 388100000
Deferred tax liabilities (net) 155100000
Deferred government grants, Non-current 0
Other non-current liabilities 0
Total non-current liabilities 552000000
Current liabilities
Current financial liabilities
Borrowings, current 0
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 149000000
Total Trade payable 149000000
Other current financial liabilities 477300000
Total current financial liabilities 626300000
Other current liabilities 1982600000
Provisions, current 42300000
Current tax liabilities (Net) 68000000
Deferred government grants, Current 0
Total current liabilities 2719200000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 3271200000
Total equity and liabilites 11104500000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 India 1359500000 4799900000
2 Far East 32700000 106300000
3 South East Asia 228500000 885800000
4 Europe 26700000 158200000
5 Middle East 250000000 914600000
6 Africa 28100000 82300000
7 Australia 74300000 244100000
8 Others 129300000 495400000
Total Segment Revenue 2129100000 7686600000
Less: Inter segment revenue 0 0
Revenue from operations 2129100000 7686600000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 India 930400000 2928000000
2 Far East 2400000 -41600000
3 South East Asia 9300000 -73700000
4 Europe 7800000 47400000
5 Middle East 57500000 76700000
6 Africa 18900000 61100000
7 Australia 40900000 83200000
8 Others 55900000 191900000
Total Profit before tax 1123100000 3273000000
i. Finance cost 0 0
ii. Other Unallocable Expenditure net off Unallocable income 273600000 273600000
Profit before tax 849500000 2157800000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 India 782100000 782100000
2 Far East 25600000 25600000
3 South East Asia 286100000 286100000
4 Europe 800000 800000
5 Middle East 218300000 218300000
6 Africa 37800000 37800000
7 Australia 97400000 97400000
8 Others 220900000 220900000
Total Segment Asset 1669000000 1669000000
Un-allocable Assets 9435500000 9435500000
Net Segment Asset 11104500000 11104500000
4 Segment Liabilities
Segment Liabilities
1 India 1417900000 1417900000
2 Far East 45100000 45100000
3 South East Asia 356300000 356300000
4 Europe 32200000 32200000
5 Middle East 479600000 479600000
6 Africa 29500000 29500000
7 Australia 141900000 141900000
8 Others 175900000 175900000
Total Segment Liabilities 2678400000 2678400000
Un-allocable Liabilities 592800000 592800000
Net Segment Liabilities 3271200000 3271200000
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of the net defined liability/asset 5400000 -43800000
2 Equity instruments through other comprehensive income - net change in fair value 1800000 -19300000
Total Amount of items that will not be reclassified to profit and loss 7200000 -63100000
2 Income tax relating to items that will not be reclassified to profit or loss 1500000 -14800000
3 Amount of items that will be reclassified to profit and loss
1 Effective portion of gains and loss on hedging instruments in a cash flow hedge 5900000 200000
Total Amount of items that will be reclassified to profit and loss 5900000 200000
4 Income tax relating to items that will be reclassified to profit or loss 1800000 200000
5 Total Other comprehensive income 9800000 -48300000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 2157800000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 2800000
Adjustments for decrease (increase) in inventories 0
Adjustments for decrease (increase) in trade receivables, current 317900000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -48900000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current -34200000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities -96300000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 138400000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 0
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 3600000
Adjustments for dividend income 4400000
Adjustments for interest income 251600000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) -388700000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 10800000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -350600000
Net cash flows from (used in) operations 1807200000
Dividends received -39600000
Interest paid 0
Interest received 0
Income taxes paid (refund) 380800000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 1386800000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 602000000
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 0
Purchase of property, plant and equipment 150600000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 44000000
Interest received 24800000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -652300000
Net cash flows from (used in) investing activities -132100000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 0
Payments of lease liabilities 22800000
Dividends paid 334700000
Interest paid 2800000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -892100000
Net cash flows from (used in) financing activities -1252400000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 2300000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 3300000
Net increase (decrease) in cash and cash equivalents 5600000
Cash and cash equivalents cash flow statement at beginning of period 182900000
Cash and cash equivalents cash flow statement at end of period 188500000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 ASA & Associates LLP Yes 31-Mar-2026


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Nucleus Software Exports Limited Vishnu Rampratap Dusadttt Managing Director Remuneration 6374000 Approvedt 6374000 0 0
2 Nucleus Software Exports Limited Poonam Bhasin Company Secretary Remuneration Approvedt 0 0 0 Textual Information(1)
3 Nucleus Software Exports Limited Parag Bhisett Executive Director Remuneration Approvedt 0 0 0 Textual Information(2)
4 Nucleus Software Exports Limited Surya Prakash Kanodia Chief Financial Officer Remuneration Approved 0 0 0 Textual Information(3)
5 Nucleus Software Exports Limited Siddhartha Mahavir Acharya Non Executive Director Any other transaction Siiting Fees 1500000 Approved 0 0 0
6 Nucleus Software Exports Limited Yasmin Javeri Krishan Non Executive Director Any other transaction Siiting Fees 1500000 Approved 0 0 0
7 Nucleus Software Exports Limited Prakash Chandra Kandpalt Non Executive Director Any other transaction Siiting Fees 1600000 Approved 0 0 0
8 Nucleus Software Exports Limited Shekar Viswanathant Non Executive Director Any other transaction Siiting Fees 1000000 Approved 0 0 0
9 Nucleus Software Exports Limited Mark McCoytt Director of Wholly Owned Subsidiary Remuneration 607000 Approved 607000 0 0
10 Nucleus Software Exports Limited Anurag Mantrit Executive Director Remuneration 0 Approved 0 0 0 Textual Information(4)
11 Nucleus Software Exports Limited Nucleus Software Foundationtt CSR Foundation of the Company Any other transaction Contribution towards CSRt 13850000 Approved 13850000 0 0 Textual Information(5)
12 Nucleus Software Exports Limited Praxis Consulting and Information services Pvt Ltdtt Interested Director Purchase of goods or services 250000 Approved 250000 0 0
13 Nucleus Software Exports Limited Yasmin Javeri Krishantt Interested Director and Director of Wholly Owned Subsidiary Remuneration 1719000 Approvedt 1719000 0 0
14 Nucleus Software Exports Limited Nucleus Software Limitedt Wholly Owned Subsidiary Interest received 130000 Approvedt 130000 0 0
15 Nucleus Software Exports Limited Nucleus Software Solutions Pte Ltd, Singaporet Wholly Owned Subsidiary Sale of goods or services 153774000 Approved 153774000 0 0
16 Nucleus Software Exports Limited Nucleus Software Solutions Pte Ltd, Singaporet Wholly Owned Subsidiary Any other transaction Reimbursement of Expensest 1214000 Approved 1214000 0 0
17 Nucleus Software Exports Limited Nucleus Software Japan Kabushiki Kaisha, Japant Wholly Owned Subsidiary Any other transaction Reimbursement of Expenses 458000 Approved 458000 0 0
18 Nucleus Software Exports Limited Nucleus Software Australia Pty Ltdt Wholly Owned Subsidiary Purchase of goods or services 19282000 Approved 19282000 0 0
19 Nucleus Software Exports Limited Nucleus Software Solutions Pte Ltd, Singaporet Wholly Owned Subsidiary Any other transaction Sales & Marketing Expenses 21467000 Approved 21467000 0 0
20 Nucleus Software Exports Limited Nucleus Software Australia Pty Ltdt Wholly Owned Subsidiary Any other transaction Sales & Marketing Expenses 12556000 Approved 12556000 0 0
21 Nucleus Software Exports Limited Nucleus Software Japan Kabushiki Kaisha, Japant Wholly Owned Subsidiary Purchase of goods or services 21419000 Approved 21419000 0 0
22 Nucleus Software Exports Limited Nucleus Software Japan Kabushiki Kaisha, Japan Wholly Owned Subsidiary Any other transaction Sales & Marketing Expenses 5475000 Approved 5475000 0 0
23 Nucleus Software Exports Limited Nucleus Software Solutions Pte Ltd, Singapore Wholly Owned Subsidiary Any other transaction Reimbursement of Expenses 3549000 Approved 3549000 0 0
24 Nucleus Software Exports Limited Nucleus Software Solutions Pte Ltd, Singapore Wholly Owned Subsidiary Any other transaction Business Management Services 40742000 Approved 40742000 0 0
25 Nucleus Software Exports Limited Nucles Software Inc, USA Wholly Owned Subsidiary Any other transaction Business Consultancy Services 4795000 Approved 4795000 0 0
Total value of transaction during the reporting period 307661000



Text Block
Textual Information(1) As per 3rd amendment Regulations issued by SEBI dated December 12, 2024, Remuneration paid by the Company or its subsidiary to its Director or KMP does not require approval of Audit Committee if the same is not material in terms of Reg 23(1).Hence remuneration details are not included for quarter ended December 31, 2024 and March 31, 2025.
Textual Information(2) As per 3rd amendment Regulations issued by SEBI dated December 12, 2024, Remuneration paid by the Company or its subsidiary to its Director or KMP does not require approval of Audit Committee if the same is not material in terms of Reg 23(1).Hence remuneration details are not included for quarter ended December 31, 2024 and March 31, 2025.
Textual Information(3) As per 3rd amendment Regulations issued by SEBI dated December 12, 2024, Remuneration paid by the Company or its subsidiary to its Director or KMP does not require approval of Audit Committee if the same is not material in terms of Reg 23(1).Hence remuneration details are not included for quarter ended December 31, 2024 and March 31, 2025.
Textual Information(4) As per 3rd amendment Regulations issued by SEBI dated December 12, 2024, Remuneration paid by the Company or its subsidiary to its Director or KMP does not require approval of Audit Committee if the same is not material in terms of Reg 23(1).Hence remuneration details are not included for quarter ended December 31, 2024 and March 31, 2025.
Textual Information(5) Interested Director (Mr. Prithvi Pal Singh Haldea) has retired from the Company on July 25, 2024 after completion of his term